Results 61 to 70 of about 11,524 (217)

A CASE OF BREST CANCER COMPLICATING BY IDIOPATHIC THROMBOCYTOPENIC PURPURA

open access: yesThe journal of the Japanese Practical Surgeon Society, 1995
We report a rare case of breast cancer complicating by idiopathic thrombocytopenic purupura (ITP) with some review of the literature. A 47-year-old woman was seen at another hospital because of subcutanious bleeding in the extrem-ities, and was diagnosed as having ITP in April 1990. In July, still under ITP treatment, the patient noticed a tumor in her
Masayuki KIMURA   +4 more
openaire   +2 more sources

Causes of Death and Comorbidities in Adult Patients With Late‐Onset Pompe Disease: A French Pompe Registry Retrospective Study

open access: yesEuropean Journal of Neurology, Volume 32, Issue 10, October 2025.
ABSTRACT Background and Objectives Mortality in Late‐Onset Pompe Disease (LOPD) has been associated with the rapid progression of respiratory and motor impairment. However, an in‐depth approach to the exact causes of death in these patients is still lacking.
Diana Maria Chitimus   +61 more
wiley   +1 more source

The impact of breast reconstruction on the quality of life of women after mastectomy

open access: yesJournal of Education, Health and Sport, 2017
Introduction: Breast cancer is the most common tumor among women. The treatment of breast cancer is becoming increasingly less mutilating but in many cases it requires drastic surgical procedures.
Agnieszka Rzońca, Adam Fronczak
doaj   +3 more sources

Rak piersi w ciąży - odmienności procesu diagnostyki i leczenia = Breast cancer during pregnancy - differences in diagnostic and treatment procedures

open access: yesJournal of Education, Health and Sport, 2016
Sowa Magdalena, Głowacka-Mrotek Iwona, Wardęcka Paulina, Winnicki Andrzej. Rak piersi w ciąży - odmienności procesu diagnostyki i leczenia = Breast cancer during pregnancy - differences in diagnostic and treatment procedures.
Magdalena Sowa   +3 more
doaj  

HLA-DR expression in melanoma: from misleading therapeutic target to potential immunotherapy biomarker

open access: yesFrontiers in Immunology
Since the advent of anti-PD1 immune checkpoint inhibitor (ICI) immunotherapy, cutaneous melanoma has undergone a true revolution with prolonged survival, as available 5-year updates for progression-free survival and overall survival demonstrate a durable
Karim Amrane   +14 more
doaj   +1 more source

Evaluation of Brest cancer by two different modalities Ultrasound and Mammography

open access: yesLibyan Journal of Medical Research, 2023
Ultrasound is an inexpensive, simple test that doesn't cause any discomfort or anxiety from claustrophobia as an Mammography  might. Ultrasound tests also don't emit any radiation, so they are safe for just about everyone. They also offer very clear images, better than those produced by an X-ray.
openaire   +1 more source

Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26-30 [PDF]

open access: yes, 2019
BACKGROUND: The benefits of chemotherapy in node-negative, hormone receptor-positive, and human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients with the 21-gene recurrence score (RS) of 18-30, particularly those with RS 26-30 ...
Cho, Young Up   +9 more
core   +1 more source

Real‐World Outcomes of Atezolizumab–Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort

open access: yesLiver International, Volume 45, Issue 10, October 2025.
ABSTRACT Background and Aims Atezolizumab–Bevacizumab (AtezoBev) was the first immunotherapy approved for hepatocellular carcinoma (HCC) in France, with initial trials primarily involving patients with viral‐related liver disease. This prospective study aimed to evaluate the efficacy of AtezoBev in a French HCC population predominantly affected by non ...
Manon Allaire   +33 more
wiley   +1 more source

Quality of Life in Iranian Breast Cancer Survivors and Affecting Factors: A Review Article

open access: yesAsian Pacific Journal of Environment and Cancer, 2019
Introduction: The breast cancer is the first common cancer among Iranian women, accounting for 24.4% of all cancers. With the improvement in disease‑free survival with advanced treatment modalities, question of quality of life (QOL) arises.
Mohammad-Reza Zaker   +2 more
doaj   +1 more source

Outcome of patients with accelerated and blast‐phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination—A FIM study

open access: yesHemaSphere, Volume 9, Issue 9, September 2025.
Abstract Accelerated‐phase (AP) or blast‐phase (BP) myeloproliferative neoplasms (MPNs) are associated with dismal prognosis, with non‐curative therapies such as hypomethylating agents (HMAs) considered in patients not eligible for intensive therapy, while some studies advocate for combination therapy with either ruxolitinib (RUXO) or venetoclax (VEN).
Corentin Orvain   +32 more
wiley   +1 more source

Home - About - Disclaimer - Privacy